PACB EPS Estimates
Pacific Biosciences of California, Inc.
$1.94
-$0.05(-2.76%)
52
Overall
40
Value
75
Tech
42
Quality
Market Cap
$618.55M
Volume
2.70M
52W Range
$1.07 - $3.44
Target Price
$2.14
PACB EPS estimates: the consensus estimate for Pacific Biosciences of California, Inc.'s current fiscal year is -$0.52 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
PACB EPS Estimates
- EPS estimate, current quarter
- $-0.13
- EPS estimate, next quarter
- $-0.13
- EPS estimate, current year
- $-0.52
- EPS estimate, next year
- $-0.48
- EPS growth, 3-year
- -9.14%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.82 |
| 2024 | $-1.13 |
| 2023 | $-1.21 |
| 2022 | $-1.40 |
| 2021 | $-0.89 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PACB | $1.94 | -2.8% | 2.70M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Pacific Biosciences of California, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW